Measles-containing-vaccine first-dose (MCV1) immunization coverage in Colombia
Colombia: Measles-containing-vaccine first-dose (MCV1) immunization coverage was 91.0% in 2025. ▬ Flat
Latest (2025)
91.0%
Change on year
down 2.2%
World rank
91st
of 194 countries
All-time high
95.0%
in 2006
All-time low
86.0%
in 2021
Years of data
26
2000–2025
Measles-containing-vaccine first-dose (MCV1) immunization coverage in Colombia, 2000–2025
Source: World Health Organization, Global Health Observatory.
Analysis
Colombia recorded 91.0% for measles-containing-vaccine first-dose (mcv1) immunization coverage in 2025.
The figure is down 2.2% on the previous year and down 3.2% over ten years.
Over the whole period, measles-containing-vaccine first-dose (mcv1) immunization coverage in Colombia peaked at 95.0% in 2006 and was at its lowest, 86.0%, in 2021.
Colombia ranks 91st of 194 countries on this measure, in the middle of the range.
Measles-containing-vaccine first-dose (MCV1) immunization coverage in Colombia, year by year
| Year | Value | Change |
|---|---|---|
| 2000 | 88.0% | — |
| 2001 | 93.0% | +5.7% |
| 2002 | 93.0% | +0.0% |
| 2003 | 93.0% | +0.0% |
| 2004 | 92.0% | -1.1% |
| 2005 | 94.0% | +2.2% |
| 2006 | 95.0% | +1.1% |
| 2007 | 95.0% | +0.0% |
| 2008 | 92.0% | -3.2% |
| 2009 | 95.0% | +3.3% |
| 2010 | 88.0% | -7.4% |
| 2011 | 88.0% | +0.0% |
| 2012 | 94.0% | +6.8% |
| 2013 | 92.0% | -2.1% |
| 2014 | 91.0% | -1.1% |
| 2015 | 94.0% | +3.3% |
| 2016 | 93.0% | -1.1% |
| 2017 | 93.0% | +0.0% |
| 2018 | 95.0% | +2.2% |
| 2019 | 95.0% | +0.0% |
| 2020 | 90.0% | -5.3% |
| 2021 | 86.0% | -4.4% |
| 2022 | 88.0% | +2.3% |
| 2023 | 93.0% | +5.7% |
| 2024 | 93.0% | +0.0% |
| 2025 | 91.0% | -2.2% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 93.0% | 88.0% | 95.0% | 10 |
| 2010s | 92.3% | 88.0% | 95.0% | 10 |
| 2020s | 90.2% | 86.0% | 93.0% | 6 |
Countries ranked near Colombia
More health data for Colombia
- Un projection of annual infant deaths, annual growth rate -1.83 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.3468 % change on previous year (2090)
- Heat deaths vs projected death rates 1,505 (2090)
- Un projection of annual infant deaths 698 (2100)
- Population ages 0-14, female, annual growth rate -0.359 % change on previous year (2025)
- Population ages 0-14, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 0-14, female, per capita 0.0979 units per person (2025)
- Population ages 0-14, male, annual growth rate -0.3835 % change on previous year (2025)
- Population ages 0-14, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 0-14, male, per capita 0.102 units per person (2025)
Frequently asked questions
- What is measles-containing-vaccine first-dose (mcv1) immunization coverage in Colombia?
- Measles-containing-vaccine first-dose (mcv1) immunization coverage in Colombia was 91.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest measles-containing-vaccine first-dose (mcv1) immunization coverage recorded in Colombia?
- The highest recorded value was 95.0% in 2006.
- What is the lowest measles-containing-vaccine first-dose (mcv1) immunization coverage recorded in Colombia?
- The lowest recorded value was 86.0% in 2021.
- How does Colombia rank for measles-containing-vaccine first-dose (mcv1) immunization coverage?
- Colombia ranks 91st out of 194 countries with data for 2025.
- Is measles-containing-vaccine first-dose (mcv1) immunization coverage rising or falling in Colombia?
- Over the last ten years it is down 3.2%. The long-run trend across the full record is flat.
- Where does this Colombia data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Measles-containing-vaccine first-dose (MCV1) immunization coverage among 1-year-olds (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 26 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).